State of Tennessee, Department of Treasury’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.43M | Hold |
43,198
| – | – | 0.02% | 527 |
|
|
2025
Q1 | $4.78M | Hold |
43,198
| – | – | 0.02% | 545 |
|
|
2024
Q4 | $5.9M | Sell |
43,198
-1,219
| -3% | -$166K | 0.02% | 502 |
|
|
2024
Q3 | $5.12M | Buy |
44,417
+3,088
| +7% | +$356K | 0.02% | 550 |
|
|
2024
Q2 | $5.69M | Sell |
41,329
-663
| -2% | -$91.3K | 0.02% | 496 |
|
|
2024
Q1 | $5.79M | Sell |
41,992
-5,000
| -11% | -$690K | 0.02% | 532 |
|
|
2023
Q4 | $6.19M | Sell |
46,992
-5,200
| -10% | -$685K | 0.02% | 466 |
|
|
2023
Q3 | $5.87M | Buy |
52,192
+8,749
| +20% | +$984K | 0.02% | 479 |
|
|
2023
Q2 | $4.1M | Hold |
43,443
| – | – | 0.02% | 536 |
|
|
2023
Q1 | $4.4M | Sell |
43,443
-2,836
| -6% | -$287K | 0.02% | 521 |
|
|
2022
Q4 | $5.53M | Buy |
46,279
+10,000
| +28% | +$1.19M | 0.03% | 449 |
|
|
2022
Q3 | $3.85M | Buy |
36,279
+2,619
| +8% | +$278K | 0.02% | 564 |
|
|
2022
Q2 | $3.28M | Sell |
33,660
-30,000
| -47% | -$2.92M | 0.02% | 609 |
|
|
2022
Q1 | $5.97M | Hold |
63,660
| – | – | 0.02% | 457 |
|
|
2021
Q4 | $5.42M | Hold |
63,660
| – | – | 0.02% | 529 |
|
|
2021
Q3 | $6.11M | Sell |
63,660
-6,340
| -9% | -$608K | 0.02% | 451 |
|
|
2021
Q2 | $6.81M | Buy |
+70,000
| New | +$6.81M | 0.03% | 444 |
|